Companies

See how salaries can vary from company to company

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of transformative central nervous system disorders in the United States. Its lead product candidate is the Fintepla/ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in Emeryville, California. view company details

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. It is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States and Europe; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. The company is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue ... view company details

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's lead product candidate is KPI-121 0.25% which has completed two Phase III clinical trials for the treatment of temporary relief of the signs and symptoms of dry eye disease; INVELTYS which has completed two Phase III clinical trials for the treatment of inflammation and pain following ocular surgery; and KPI-285, a MPP receptor tyrosine kinase ... view company details

Supernus Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy and migraine. The company's product candidates comprise SPN-812, a viloxazine hydrochloride, which is in Phase III clinical trial that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-8... view company details

Foamix Pharmaceuticals Ltd., a late clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations for dermatological therapy in the United States, France, Denmark, and Germany. Its lead product candidates include FMX101, a novel topical foam formulation of the antibiotic minocycline that has completed third pivotal Phase III clinical trial for the treatment of moderate-to-severe acne; and FMX103, which is in Phase III clinical trial for the treatment of moderate-to-severe papulopustular rosacea. The company's product pipeline includes FCD105 and FMX109 fo... view company details

Pernix Group is a leading construction company, offering diversified general contracting, design-build, preconstruction, construction management, EPC and O&M services to private clients and public agencies. We have provided construction services since 1995 and have established a strong reputation within the Government, Commercial & Industrial, and Power markets by executing complex projects on-time and within budget while adhering to strict quality control measures. view company details

3Q Digital is leading the disruption of the growth marketing industry by turning our clients into market leaders and household names across B2C, B2B, ecommerce, and FinTech. We're independent and values-driven, and the way we work reflects our Silicon Valley roots: we're relentless, curious, and accept no limits in driving growth for our clients and each other. We offer services including SEM, SEO, social advertising, display, mobile, analytics, CRO, creative, and business strategy. We build and execute strategies to enable clients to capitalize on opportunities, break through barriers to grow... view company details

Cedar Ridge Home Services is a construction company based out of 15 Lincoln St, East Hampton, NY, United States. view company details

Code Red Safety is a provider of safety equipment rental, rescue and training services for chemical, construction, oil and gas industries. view company details

Fabcon manufactures and supplies pre-stressed concrete wall panels, traffic barriers, floor slabs and wind turbines for construction applications. view company details

Horvath Roofing Inc is a construction company based out of 132 Carbon St, Toledo, Ohio, United States. view company details

Master Floor Co is a construction company based out of 2714 Oro Dam Blvd W, Oroville, California, United States. view company details

Mechanical Products Nevada is a construction company based out of 2701 Crimson Canyon Dr # 110, Las Vegas, Nevada, United States. view company details

Rockwell Roofing Inc is a construction company based out of 44 Pond St, Leominster, Massachusetts, United States. view company details

SG Blocks, Inc. engages in fabricating modules for construction of buildings in the United States. The company redesigns, repurposes, and converts heavy-gauge steel cargo shipping containers into green building blocks for commercial, industrial, and residential building construction; and purpose-built modules, or prefabricated steel modular units for construction. It also provides engineering and project management services related to the use of modified containers in construction. The company serves architects, landowners, builders, and developers. SG Blocks, Inc. was founded in 2007 and is h... view company details

Vermeer is a manufacturer of agriculture, construction, surface mining, tree care, organic recycling and wood waste processing equipments. view company details

Walter P Moore offers structural, diagnostics, civil, traffic, parking, transportation, enclosure and construction engineering services. view company details

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology for the treatment of cancer and rare genetic diseases. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refractory acute myeloid leukemia (R/R AML), as well as to treat patients with newly diagnosed AML; and IDHIFA, an oral targeted inhibitor for patients with R/R AML and an isocitrate dehydrogenase 2 mutation. It is also developing TIBSOVO, which has comp... view company details

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and Soliris (eculizumab), a monoclonal antibody for the treatment of PNH, atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis. It also provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatm... view company details

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer and other diseases in North America, Europe, and the Asia Pacific. It provides BRAFTOVITM (encorafenib) capsules in combination with MEKTOVI (binimetinib) tablets for the treatment of patients with unresectable or metastatic melanoma with a BRAF mutation. The company's lead clinical programs include encorafenib and binimetinib that are investigated in approximately 30 clinical trials for various solid tumor indications, including ... view company details